Was Crystal Pharmatech hit by ransomware?

Crystal Pharmatech was listed by the Qilin ransomware operation (United States), and stolen data was published on the group's leak site. Darkfield tracks this disclosure with the original leak post, screenshot and group context.

Who is the Qilin ransomware group?

Qilin is a ransomware operator tracked by Darkfield. See the full operator dossier for its known victims, sectors targeted, IOCs and leak-site infrastructure.

What data was leaked in the Crystal Pharmatech breach?

Qilin published data attributed to Crystal Pharmatech. Darkfield captured the leak post and a screenshot of the listing.

Ransomware victim disclosure

← All victims

Crystal Pharmatech

Claimed by Qilin · listed 2 days ago

Age

since listed · data leaked

Status timeline

ListedAug 6, 2026
Data leakeddate unknown

At a glance

Group: Qilin
Status: Data leaked
Country: United States
Sector: Healthcare
Listed on leak site: Aug 6, 2026

About the victim

AI dossier — public-source company profile

Crystal Pharmatech is a global CDMO and CRO specializing in solid-state formulation, drug development, and manufacturing services. The company operates across small-molecule pharmaceuticals, biologics, and nucleic acid therapeutics, with facilities in Asia-Pacific and the United States, and provides services including API development, crystallization, formulation, analytical characterization, and GMP-compliant manufacturing.

Industry: Contract Development and Manufacturing Organization (CDMO) & Clinical Research Organization (CRO) — Pharmaceutical

Attack summary

Severity: high — Crystal Pharmatech is a pharmaceutical CDMO/CRO with access to proprietary drug formulations, manufacturing processes, clinical trial data, and client intellectual property. Exfiltration of such data poses significant risk to pharmaceutical clients, competitive harm, and potential exposure of clinical/regulatory information. The lack of detailed proof or ransom demand does not reduce the sensitivity of the sector and likely data types involved.

The ransomware group Qilin claims to have published data from Crystal Pharmatech. No specific details about the attack method (encryption vs. exfiltration) or data categories are provided in the available post excerpt.

high

What the group claims

N/A

Sources

Source

Indexed 2 days ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About Qilin

Qilin is a ransomware group that emerged in October 2022, operating with primarily financial motivations through targeted attacks against organizations across multiple sectors. The group appears to operate independently with limited public information available regarding their specific country of origin or affiliations to other ransomware families. Qilin employs double extortion tactics, typically exfiltrating sensitive data before deploying their encryption payload, though specific details about their initial access vectors and technical tools remain less documented in public security research. The group has demonstrated a broad targeting approach, with their 1645 known victims spanning multiple countries including the United States, France, Canada, United Kingdom, and Germany, with particular focus on manufacturing, technology, healthcare, and business services sectors. Based on available intelligence reporting, Qilin remains an active threat as of recent assessments, continuing their ransomware operations without significant reported law enforcement disruption. The group has been linked to 2,133 public disclosures across our corpus. First observed on a leak site on October 8, 2022; most recent post August 7, 2026. The operation is currently active.

Timeline of this disclosure

August 6, 2026Crystal Pharmatech listed by Qilinon the group's public leak site

Other recent disclosures by Qilin

Qilin has been linked to 2,133 public victims on Darkfield. A sample of the most recent:

See the full Qilin dossier →

Sector and geography

This disclosure adds to ransomware activity in the Healthcare sector, which has 2,608 disclosures indexed across all operators we track. Geographically, Crystal Pharmatech is reported in United States, a country with 3,159 ransomware disclosures in our corpus.

If your organisation is affected

A listing by Qilin means Crystal Pharmatech appeared on a ransomware extortion site and data attributed to it has been published. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
Report the incident to your national CERT, CISA (United States), as required for your jurisdiction.
Monitor for the data appearing on Qilin's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.